Key Points
- Insider sale: Aveanna Healthcare insider Patrick Cunningham sold 125,000 shares on May 20 at an average price of $7.59, totaling $948,750. After the transaction, he still held 212,755 shares.
- Recent earnings beat expectations: The company reported quarterly EPS of $0.18, ahead of the $0.13 consensus, while revenue rose 15.9% year over year to $647.92 million.
- Mixed analyst view but positive outlook overall: Analysts have issued a “Moderate Buy” consensus with an average price target of $10.50, though ratings have been mixed with both upgrades and downgrades in recent months.
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) insider Patrick Cunningham sold 125,000 shares of the company's stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total transaction of $948,750.00. Following the sale, the insider owned 212,755 shares in the company, valued at $1,614,810.45. The trade was a 37.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Aveanna Healthcare Stock Down 0.1%
AVAH stock opened at $7.67 on Friday. The company's 50 day moving average price is $6.75 and its 200 day moving average price is $7.86. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.73 and a fifty-two week high of $10.32. The firm has a market capitalization of $1.67 billion, a price-to-earnings ratio of 6.50, a PEG ratio of 0.91 and a beta of 1.93.
Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last released its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm had revenue of $647.92 million for the quarter, compared to analyst estimates of $613.22 million. The firm's revenue was up 15.9% compared to the same quarter last year. On average, equities research analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.56 EPS for the current fiscal year.
Analysts Set New Price Targets
Several equities analysts recently commented on AVAH shares. Zacks Research lowered Aveanna Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, February 3rd. Raymond James Financial raised Aveanna Healthcare from an "outperform" rating to a "strong-buy" rating and set a $13.00 target price on the stock in a report on Friday, March 20th. Weiss Ratings lowered Aveanna Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a report on Monday, April 6th. Stephens upgraded shares of Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and increased their price target for the company from $10.00 to $11.00 in a research note on Friday, May 15th. Finally, BMO Capital Markets dropped their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an "outperform" rating on the stock in a research note on Friday, March 20th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, Aveanna Healthcare has a consensus rating of "Moderate Buy" and an average price target of $10.50.
Check Out Our Latest Stock Analysis on AVAH
Hedge Funds Weigh In On Aveanna Healthcare
Several hedge funds have recently made changes to their positions in the company. Bank of America Corp DE grew its holdings in shares of Aveanna Healthcare by 64.2% during the first quarter. Bank of America Corp DE now owns 402,510 shares of the company's stock worth $2,592,000 after purchasing an additional 157,368 shares during the last quarter. Smith Group Asset Management LLC grew its holdings in shares of Aveanna Healthcare by 34.3% during the first quarter. Smith Group Asset Management LLC now owns 263,669 shares of the company's stock worth $1,698,000 after purchasing an additional 67,393 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Aveanna Healthcare by 22.1% during the first quarter. EverSource Wealth Advisors LLC now owns 17,552 shares of the company's stock worth $113,000 after purchasing an additional 3,172 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Aveanna Healthcare by 56.3% during the first quarter. The Manufacturers Life Insurance Company now owns 36,509 shares of the company's stock worth $235,000 after purchasing an additional 13,155 shares during the last quarter. Finally, Quantinno Capital Management LP purchased a new position in shares of Aveanna Healthcare during the first quarter worth about $111,000. Hedge funds and other institutional investors own 87.96% of the company's stock.
About Aveanna Healthcare
(
Get Free Report)
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
